Bratislava, 15/07/2016 (Agence Europe) - The European Parliament and Council are still active in tackling the exorbitant price of some new medicines. The most recent example is a workshop held at the European Parliament on Thursday 14 July to help in the drafting of an own initiative report by Soledad Cabezon Ruiz (S&D, Spain).
There were demonstrations in Spain in 2015 against the high price of Sovaldi (sofosbuvir molecule), a medicine for hepatitis C, which cost back then more than...